SCM
MRK icon

SKBA Capital Management’s Merck MRK Stock Holding History

SKBA Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.3M Hold
151,872
– – 2.51% 12
2025
Q4 		$16M Sell
151,872
-13,530
-8% -$1.27M 2.27% 14
2025
Q3 		$13.9M Sell
165,402
-1,370
-0.8% -$113K 1.92% 20
2025
Q2 		$13.2M Sell
166,772
-370
-0.2% -$29.4K 1.9% 21
2025
Q1 		$15M Buy
167,142
+1,487
+0.9% +$139K 2.23% 10
2024
Q4 		$16.5M Sell
165,655
-6,900
-4% -$711K 2.6% 7
2024
Q3 		$19.6M Sell
172,555
-1,200
-0.7% -$143K 2.91% 6
2024
Q2 		$21.5M Sell
173,755
-2,500
-1% -$322K 3.45% 2
2024
Q1 		$23.3M Sell
176,255
-1,380
-0.8% -$170K 3.64% 2
2023
Q4 		$19.4M Buy
177,635
+12,300
+7% +$1.28M 3.26% 4
2023
Q3 		$17M Sell
165,335
-100
-0.1% -$10.8K 3.14% 3
2023
Q2 		$19.1M Sell
165,435
-21,900
-12% -$2.49M 3.44% 2
2023
Q1 		$19.9M Sell
187,335
-700
-0.4% -$75.6K 3.71% 1
2022
Q4 		$20.9M Sell
188,035
-190
-0.1% -$19.4K 3.86% 1
2022
Q3 		$16.2M Buy
188,225
+700
+0.4% +$62.5K 3.44% 3
2022
Q2 		$17.1M Sell
187,525
-200
-0.1% -$17.7K 3.42% 3
2022
Q1 		$15.4M Buy
187,725
+1,100
+0.6% +$86.7K 2.78% 8
2021
Q4 		$14.3M Buy
186,625
+28,900
+18% +$2.3M 2.69% 8
2021
Q3 		$11.8M Buy
157,725
+1,575
+1% +$120K 2.36% 13
2021
Q2 		$12.1M Sell
156,150
-48,629
-24% -$3.62M 2.38% 13
2021
Q1 		$15.1M Buy
204,779
+23,161
+13% +$1.71M 2.39% 10
2020
Q4 		$14.2M Buy
181,618
+120,205
+196% +$9.19M 2.37% 10
2020
Q3 		$4.86M Buy
+61,413
New +$4.81M 0.97% 50

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SKBA Capital Management's MRK Position: Q1 2026 in Review

SKBA Capital Management held its Merck (MRK) position steady in Q1 2026 at 151,872 shares worth $18.3M. The position accounts for 2.51% of the portfolio, ranked #12.

SKBA Capital Management first reported a position in MRK in Q3 2020 and has held it in 23 quarters since. The position peaked at $23.3M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SKBA Capital Management held 151,872 shares of Merck worth $18.3M as of Q1 2026.
  • SKBA Capital Management left its Merck share count unchanged in Q1 2026.
  • Merck made up 2.51% of SKBA Capital Management's portfolio in Q1 2026, its #12 holding.
  • SKBA Capital Management first reported a position in Merck in Q3 2020 and has held it in 23 quarters since.
  • SKBA Capital Management's Merck position peaked at $23.3M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.